We are live on
!
Find out more
T
Tahithromos Portfolio holdings
AUM
$71.9M
1-Year Est. Return
0.24%
This Fund
S&P 500
This Quarter
Est. Return
-3.13%
1 Year Est. Return
-0.24%
3 Year Est. Return
+16.44%
5 Year Est. Return
+53.61%
10 Year Est. Return
–
AUM
$105M
AUM Growth
-$2.29M
(-2.1%)
Cap. Flow
-$102M
Cap. Flow
% of AUM
-97%
Top 10 Holdings %
Top 10 Hldgs %
86.22%
Holding
25
New
8
Increased
5
Reduced
6
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$4.23M |
| 2 |
GG
Goldcorp Inc
GG
|
+$4.04M |
| 3 |
Analog Devices
ADI
|
+$3.94M |
| 4 |
Newmont
NEM
|
+$3.71M |
| 5 |
Cisco
CSCO
|
+$2.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$13.3M |
| 2 |
Dr. Reddy's Laboratories
RDY
|
+$3.2M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$2.17M |
| 4 |
Community Health Systems
CYH
|
+$1.11M |
| 5 |
CF Industries
CF
|
+$819K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.8% |
| 2 | Technology | 15.49% |
| 3 | Materials | 7.97% |
| 4 | Consumer Discretionary | 6.99% |
| 5 | Healthcare | 4.56% |
Similar funds
GC
DCM
XS
SCM
BSCP
FMA
MSTVIM
LA
Tahithromos's Q4 2015 Portfolio in Review
As of Q4 2015, Tahithromos held 25 positions worth $105M, down 2.1% from $107M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Tahithromos withdrew a net $102M in Q4 2015, closing 3 positions and reducing 6 holdings. Its most notable exit was Dr. Reddy's Laboratories, an estimated $3.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 14% a quarter earlier, followed by Technology and Materials.
Against the trend, Tahithromos opened a new position in Goldcorp Inc worth $3.67M.
- Tahithromos's largest Q4 2015 buy was Goldcorp Inc: 317,945 shares worth $3.67M.
- Tahithromos added most to HDFC Bank in Q4 2015, an estimated $4.23M increase.
- Tahithromos's biggest Q4 2015 reduction was SPDR Gold Trust, cutting an estimated $13.3M.
- Tahithromos fully exited Dr. Reddy's Laboratories in Q4 2015, selling an estimated $3.2M.
- Tahithromos's ten largest holdings make up 86% of its $105M portfolio in Q4 2015.
- Tahithromos opened 8 new positions and closed 3 in Q4 2015.
- Tahithromos's portfolio value fell 2.1% quarter-over-quarter to $105M.
Based on Tahithromos's 13F filing for Q4 2015, filed 3 Feb 2016.